A Stanford-led study finds that remnants of an ancient viral infection may be the reason humans and other primates evolved to have larger hearts and bodies.
Stanford scientists have devised a way to use positron emission tomography to watch the movement of a single cell injected into a lab mouse in real time.
Stanford experts provide tips for helping young children learn to wear a cloth mask to help prevent the spread of COVID-19.
Sampling one's own lower nasal passages for COVID-19 virus is as efficient as swabs that sample deep in the nasal cavity, Stanford study finds.
In breast and lung cancer patients with metastatic disease, seeds of metastasis were often planted before the primary tumor was diagnosed, a study finds.
A NOVA special featured Rhiju Das and the OpenVaccine project, in which gamers help scientists find an RNA molecule configuration for a COVID-19 vaccine.
The experts on Stanford Medicine's molecular tumor board brainstorm new ways to attack individual patients' tumors at the genetic level.
Co-infection with SARS-CoV-2 and other respiratory pathogens is more common than previously expected, according to a Stanford study.
Stanford researchers are working on a test to identify early-stage lung cancer by detecting tumor-specific mutations in bits of DNA in the bloodstream.
Stanford researchers study stem-cell-derived human heart muscle cells on the International Space Station to learn effects of microgravity.
Mammalian cells use a label to distinguish self from non-self circular RNA molecules. Foreign molecules can trigger anti-cancer immune responses.
The Myc oncogene helps cancer cells stockpile the fat, or lipids, necessary for rapid growth. Blocking this activity causes human tumors in mice to shrink.
Stanford researcher Eleni Linos turned to social media to see if it was a more effective way to spread information about skin cancer and tanning to youth.
The bacteria in our gut make tiny, previously unidentified proteins that could shed light on human health and advance drug development.
Frustrated by the poor options for their patients, two neurosurgery residents left to study basic science at Stanford, developing a drug for brain tumors.
Stanford clinicians take their cue from sports and election predictions to calculate an "in-game probability" of success when treating cancer patients.